Townson Sharon — SEC Form 4 filings
SEC reporting owner CIK 1855689. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-07.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-06-05 to 2026-07-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 5 filings — 21,155 shares, $423,931 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 5,600 shares @ $23.25 ($130,197) in Monte Rosa Therapeutics, Inc., filed 2026-07-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | 7 | — | 6 legs · 21,155 sh · $423,931 | 13 |
Form 4 filings — Townson Sharon
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-07 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Option exercise (M): 6,000 @ $6.14 · Sale (S): 5,600 @ $23.25 · Sale (S): 400 @ $24.13 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Option exercise (M): 3,000 @ $6.14 · Sale (S): 3,000 @ $20 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Option exercise (M): 3,000 @ $6.14 · Sale (S): 3,000 @ $19 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Option exercise (M): 6,000 @ $6.14 · Sale (S): 6,000 @ $19.87 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/award (A): 35,000 · Sale (S): 3,155 @ $15.17 · Grant/award (A): 158,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/award (A): 36,000 · Grant/award (A): 161,000 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1855689 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →